Literature DB >> 31828425

Hyperreflective foci in predicting the treatment outcome of antivascular endothelial growth factor in neovascular age-related macular degeneration.

Yun Hsia1, Chang-Hao Yang1,2, Yi-Ting Hsieh1, Chung-May Yang1,2, Tzyy-Chang Ho1, Tso-Ting Lai3,4.   

Abstract

PURPOSE: To describe the optical coherence tomographic findings of hyperreflective foci (HF) in neovascular age-related macular degeneration and evaluate the use of HF to predict visual outcome after antivascular endothelium growth factor (anti-VEGF) therapy.
METHODS: This was a post-hoc analysis of a retrospective cohort study. Hyperreflective foci were localized in the inner retina, outer retina, or subretinal fluid (SRF) layer. The treatment response of HF was recorded. The association between HF and visual outcome was analyzed.
RESULTS: We enrolled 126 eyes. Hyperreflective foci involving more than one layer were associated with poor initial visual acuity (P < 0.001). Hyperreflective foci in each layer at baseline were negatively correlated with baseline visual acuity. At 3 months posttreatment, HF in the SRF layer had decreased significantly (P = 0.003), which was faster compared with HF in other layers. Baseline HF status at each layer was not associated with final visual outcome. The eyes with reduced HF in the SRF at 3 months had better visual improvement at 12 months (P = 0.038).
CONCLUSION: Hyperreflective foci involving multiple layers were associated with poor initial visual acuity but not with final visual outcome. With anti-VEGF treatment, HF in the SRF layer resolved faster, which may predict better visual outcome.

Entities:  

Keywords:  Antivascular endothelial growth factor; Hyperreflective foci; Neovascular age-related macular degeneration; Subretinal fluid

Year:  2019        PMID: 31828425     DOI: 10.1007/s00417-019-04546-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  6 in total

1.  Predicting treat-and-extend outcomes and treatment intervals in neovascular age-related macular degeneration from retinal optical coherence tomography using artificial intelligence.

Authors:  Hrvoje Bogunović; Virginia Mares; Gregor S Reiter; Ursula Schmidt-Erfurth
Journal:  Front Med (Lausanne)       Date:  2022-08-09

2.  Association between inflammatory cytokines in the aqueous humor and hyperreflective foci on optical coherence tomography in patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Jianbo Mao; Nuo Chen; Shian Zhang; Yuyan Fang; Zicheng Zheng; Sulan Wu; Xin Ye; Yijing Chen; Yiqi Chen; Lijun Shen
Journal:  Front Med (Lausanne)       Date:  2022-09-23

3.  The Efficacy of Anti-VEGF Therapy for Putative or Visible CNV in Central Serous Chorioretinopathy by Optical Coherence Tomography Angiography.

Authors:  Yumeng Zhang; Jingfa Zhang; Xiaodong Sun
Journal:  J Ophthalmol       Date:  2022-09-28       Impact factor: 1.974

4.  Imaging Hyperreflective Foci as an Inflammatory Biomarker after Anti-VEGF Treatment in Neovascular Age-Related Macular Degeneration Patients with Optical Coherence Tomography Angiography.

Authors:  Jing Wu; Chaoyang Zhang; Qian Yang; Hai Xie; Jingting Zhang; Qinghua Qiu; Kun Liu; Dawei Luo; Fang Liu; Jingfa Zhang
Journal:  Biomed Res Int       Date:  2021-02-03       Impact factor: 3.411

5.  Optical Coherence Tomography Angiography Characteristics Serve as Retinal Vein Occlusion Therapeutic Biomarkers for Dexamethasone Intravitreal Implant.

Authors:  Ke Shi; Xiaodong Sun; Jingfa Zhang
Journal:  Dis Markers       Date:  2021-10-13       Impact factor: 3.434

6.  Association between Inflammatory Factors in the Aqueous Humor and Hyperreflective Foci in Patients with Intractable Macular Edema Treated with Antivascular Endothelial Growth Factor.

Authors:  Min Li; Jing Li; Kaichuan Chen; Jia Wang; Minjie Sheng; Bing Li
Journal:  Dis Markers       Date:  2021-06-07       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.